NF-kappaB: linking inflammation and immunity to cancer development and progression
about
Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancerMaternal undernutrition and cardiometabolic disease: a Latin American perspectiveMicroRNA-19b-3p Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF11Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesBrd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelAAn atypical E3 ligase zinc finger protein 91 stabilizes and activates NF-kappaB-inducing kinase via Lys63-linked ubiquitinationNegative regulation of protein phosphatase 2Cbeta by ISG15 conjugationTRIM40 promotes neddylation of IKKγ and is downregulated in gastrointestinal cancersFER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-kappaBTheileria-induced constitutive IKK activation is independent of functional Hsp90Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.Copine-I represses NF-kappaB transcription by endoproteolysis of p65Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors.The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signallingInvolvement of linear polyubiquitylation of NEMO in NF-kappaB activationThe human homolog of the Drosophila headcase protein slows down cell division of head and neck cancer cellsStabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasionRo52-mediated monoubiquitination of IKK{beta} down-regulates NF-{kappa}B signallingGlycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradationEssential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signalingIs NF-kappaB a good target for cancer therapy? Hopes and pitfallsA miR-19 regulon that controls NF-κB signalingNeutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor modelCentral role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonistMicroRNAs in NF-kappaB signalingA human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responsesMucins in cancer: function, prognosis and therapyInflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotionp120-catenin mediates inflammatory responses in the skinDeregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancerMicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery componentsLuteolin, a flavonoid with potential for cancer prevention and therapyMolecular mechanisms involved in farnesol-induced apoptosisProinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cellsRAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesisWhy cancer and inflammation?Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRILHow Mouse Macrophages Sense What Is Going On.The emerging role of FTY720 (Fingolimod) in cancer treatmentReview: the Contribution of both Nature and Nurture to Carcinogenesis and Progression in Solid Tumours
P2860
Q21135494-C1182B81-A28D-4CEA-904D-9311C82B0D0CQ21146681-BB68FDF1-FCE3-4A56-B306-2D67CB499520Q24289060-34F3A64A-D956-49B9-BB2C-B4E4368E95FCQ24289511-A0C2F9F6-2087-42A5-B3BA-242AAC29F070Q24293271-95A65310-2542-4B96-B89F-5A8BA7E8906CQ24294345-CB652FB5-CC26-4265-A616-44636D19D9F0Q24298148-38563BA5-32DB-4553-BCF9-D6F42A43CF02Q24299200-18B91204-3D1E-4A93-9785-7BF4125C07E2Q24300387-215423D6-B1E5-4BC4-908A-3BE634FFA9F9Q24300863-A7B3A166-A377-4AB7-A6A6-852E8F14C937Q24304385-259D7B47-F00F-45B6-930E-73952EC41BA2Q24307551-335DCF90-86ED-49BB-B4D1-A535FC69C4FFQ24312920-7E773F35-5C17-448D-AB02-F9616B7BF3E5Q24314649-0BFBF258-03FF-47CF-871E-A505945F2ABBQ24315943-249AFB4A-4D46-4AC2-83F5-DA13363F6279Q24318687-92545377-2357-4295-BCE8-60CC9059D97DQ24321517-9C97775C-3C51-4A8D-B84F-BA98811E3DDEQ24324531-B5D5D790-C16E-42F7-B19D-1A4D8E6E62A1Q24336114-2C38C78F-27D0-4CE1-B69B-0A668053F3E8Q24337661-94D203DE-D219-46BB-863E-B77CD3540A17Q24570128-FBD83726-8114-4454-BA1E-C44B6A0D88E6Q24602478-5DAADC51-6F71-4DE0-B48D-FA9A86C52EE1Q24612339-0A763B83-BEBE-438C-A19B-D5A690256D35Q24623979-16B3DE41-5365-4CBF-9757-4FB23819E54CQ24630097-6A8EA0F5-B815-4B85-B28E-355F10CE7D7EQ24630221-72DE8AF9-FAA4-4168-9045-0A706B46055DQ24633765-006EAB65-374B-4082-8CF3-6C74D4E737CBQ24644807-E156812C-449C-45C8-83E2-803AFC5EE741Q24647606-D112AE79-5FB9-4CB5-90F4-F658D56C2095Q24648025-60DFCC37-79A1-4F41-8C41-6C285F3F7784Q24648543-BA8F3330-FCCF-479F-8685-0AB93CB88E50Q24652632-DE22BCCC-AE13-4139-AACA-6E7704B30782Q24655100-19B84064-2114-4A42-A45E-29A4715CEAEEQ24658240-A151F822-B5C3-4344-A1F0-30226A366EA7Q24658378-081CC580-F2C0-4A9A-9145-ABA1A90CCF99Q24680891-CFDB6B89-C093-4B99-A6A0-90302D794BFFQ24681342-9325D4EB-BC6D-4AE9-BD11-9F5588AE4005Q26745544-EA55433C-0556-4CA6-B9D2-6895B95CE0DBQ26748927-8928AC34-61C5-45C3-A2B3-7D4071ECDCBAQ26749322-3E46EC2A-44E1-42BE-8D45-E6EF701554F6
P2860
NF-kappaB: linking inflammation and immunity to cancer development and progression
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
NF-kappaB: linking inflammation and immunity to cancer development and progression
@ast
NF-kappaB: linking inflammation and immunity to cancer development and progression
@en
type
label
NF-kappaB: linking inflammation and immunity to cancer development and progression
@ast
NF-kappaB: linking inflammation and immunity to cancer development and progression
@en
prefLabel
NF-kappaB: linking inflammation and immunity to cancer development and progression
@ast
NF-kappaB: linking inflammation and immunity to cancer development and progression
@en
P3181
P356
P1476
NF-kappaB: linking inflammation and immunity to cancer development and progression
@en
P2093
Michael Karin
P304
P3181
P356
10.1038/NRI1703
P407
P577
2005-10-01T00:00:00Z